These findings indicate a tumor suppressor role for miR-188-5p via the targeting of FGF5, which mainly activates FGFR1c with heparan sulfate as a co-factor in human HCC (Table 1; Fang et al., 2015). This evidence concerns the gene FGF5 and hepatocellular carcinoma.